Skip to main content

Immunohistochemistry in the Differential Diagnosis of Adult and Pediatric Brain Tumors

  • Chapter
  • First Online:
  • 1415 Accesses

Part of the book series: Pediatric Cancer ((PECA,volume 2))

Abstract

Immunohistochemical stains are of increasing importance in evaluating adult and pediatric intracranial neoplasms. Surgical neuropathologists frequently utilize these in the subclassification and characterization of CNS neoplasms, assessment of prognosis, identification of therapeutic targets, and possibly helping predict response to therapy. Here, we review existing and novel antibodies that are of immediate utility in the differential diagnosis of adult and pediatric CNS neoplasms. The discussion focuses on the role of various immunostains in differentiating non-neoplastic brain from glioma, in subtyping glial and non-glial tumors, and in providing clinically relevant prognostic and predictive information.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Ambrosini-Spaltro A, Eusebi V (2010) Meningeal hemangiopericytomas and hemangiopericytoma/solitary fibrous tumors of extracranial soft tissues: a comparison. Virchows Arch 456:343–354

    Article  PubMed  Google Scholar 

  • Antonelli M, Buttarelli FR, Arcella A, Nobusawa S, Donofrio V, Oghaki H, Giangaspero F (2010) Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas. J Neurooncol 99:209–215

    Article  PubMed  CAS  Google Scholar 

  • Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74–79

    PubMed  CAS  Google Scholar 

  • Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A (2009) Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol 118:599–601

    Article  PubMed  CAS  Google Scholar 

  • Capper D, Sahm F, Hartmann C, Meyermann R, von Deimling A, Schittenhelm J (2010a) Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes. Am J Surg Pathol 34:1199–1204

    Article  PubMed  Google Scholar 

  • Capper D, Reuss D, Schittenhelm J, Hartmann C, Bremer J, Sahm F, Harter PN, Jeibmann A, von Deimling A (2010b) Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. Acta Neuropathol 121:241–252

    Article  PubMed  Google Scholar 

  • Clarkson KS, Sturdgess IC, Molyneux AJ (2001) The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A). J Clin Pathol 54:196–200

    Article  PubMed  CAS  Google Scholar 

  • Cosgrove M, Fitzgibbons PL, Sherrod A, Chandrasoma PT, Martin SE (1989) Intermediate filament expression in astrocytic neoplasms. Am J Surg Pathol 13:141–145

    Article  PubMed  CAS  Google Scholar 

  • Deb P, Sharma MC, Tripathi M, Sarat CP, Gupta A, Sarkar C (2006) Expression of CD34 as a novel marker for glioneuronal lesions associated with chronic intractable epilepsy. Neuropathol Appl Neurobiol 32:461–468

    Article  PubMed  CAS  Google Scholar 

  • Edgar MA, Rosenblum MK (2008) The differential diagnosis of central nervous system tumors: a critical examination of some recent immunohistochemical applications. Arch Pathol Lab Med 32:500–509

    Google Scholar 

  • Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, Westphal M, Schackert G, Meyermann R, Pietsch T, Reifenberger G, Weller M, Loeffler M, von Deimling A (2010) Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol 120:707–718

    Article  PubMed  Google Scholar 

  • Hattab EM, Tu PH, Wilson JD, Cheng L (2005) OCT4 immunohistochemistry is superior to placental alkaline phosphatase (PLAP) in the diagnosis of central nervous system germinoma. Am J Surg Pathol 29:368–371

    Article  PubMed  Google Scholar 

  • Herpers MJ, Budka H (1984) Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma. Acta Neuropathol (Berl) 64:265–272

    Article  CAS  Google Scholar 

  • Hoang MP, Amirkhan RH (2003) Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma. Am J Surg Pathol 27:1152–1156

    Article  PubMed  Google Scholar 

  • Judkins AR, Burger PC, Hamilton RL, Kleinschmidt-DeMasters B, Perry A, Pomeroy SL, Rosenblum MK, Yachnis AT, Zhou H, Rorke LB, Biegel JA (2005) INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma. J Neuropathol Exp Neurol 64:391–397

    PubMed  CAS  Google Scholar 

  • Kim YH, Nobusawa S, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, Sure U, Wrede K, Nakazato Y, Tanaka Y, Vital A, Mariani L, Stawski R, Watanabe T, De Girolami U, Kleihues P, Ohgaki H (2010) Molecular classification of low-grade diffuse gliomas. Am J Pathol 177:2708–2714

    Article  PubMed  Google Scholar 

  • Krishna M (2010) Diagnosis of metastatic neoplasms: an immunohistochemical approach. Arch Pathol Lab Med 134:207–215

    PubMed  Google Scholar 

  • Kros JM, Van Eden CG, Stefanko SZ, Waayer-Van BM, van der Kwast TH (1990) Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas. Cancer 66:1204–1212

    Article  PubMed  CAS  Google Scholar 

  • Kurtkaya-Yapıcıer O, Scheithauer BW, Hebrink D, James CD (2002) P53 in nonneoplastic central nervous system lesions: an immunohistochemical and genetic sequencing study. Neurosurgery 51:1246–1255

    Article  PubMed  Google Scholar 

  • Meyer J, Pusch S, Balss J, Capper D, Mueller W, Christians A, Hartmann C, von Deimling A (2010) PCR- and restriction endonuclease-based detection of IDH1 mutations. Brain Pathol 20:298–300

    Article  PubMed  CAS  Google Scholar 

  • Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P, Rutka JT, Pfister S, Taylor MD (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29(11):1408–1414

    Article  PubMed  Google Scholar 

  • Oakley GJ, Fuhrer K, Seethala RR (2008) Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma versus chondrosarcoma differential: a tissue microarray-based comparative analysis. Mod Pathol 21:1461–1469

    Article  PubMed  CAS  Google Scholar 

  • Oh D, Prayson RA (1999) Evaluation of epithelial and keratin markers in glioblastoma multiforme: an immunohistochemical study. Arch Pathol Lab Med 123:917–920

    PubMed  CAS  Google Scholar 

  • Ohnishi A, Sawa H, Tsuda M, Sawamura Y, Itoh T, Iwasaki Y, Nagashima K (2003) Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas. J Neuropathol Exp Neurol 62:1052–1059

    PubMed  CAS  Google Scholar 

  • Patil S, Perry A, Maccollin M, Dong S, Betensky RA, Yeh TH, Gutmann DH, Stemmer-Rachamimov AO (2008) Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas. Brain Pathol 18:517–519

    PubMed  CAS  Google Scholar 

  • Takei H, Yogeswaren ST, Wong KK, Mehta V, Chintagumpala M, Dauser RC, Lau CC, Adesina AM (2008) Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival. J Neurooncol 86:183–190

    Article  PubMed  Google Scholar 

  • Vujovic S, Henderson S, Presneau N, Odell E, Jacques TS, Tirabosco R, Boshoff C, Flanagan AM (2006) Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 209:157–165

    Article  PubMed  CAS  Google Scholar 

  • Weinbreck N, Marie B, Bressenot A, Montagne K, Joud A, Baumann C, Klein O, Vignaud JM (2008) Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear cell renal cell carcinoma in the brain: utility of aquaporin 1 combined with cytokeratin AE1/AE3 immunostaining. Am J Surg Pathol 32:1051–1059

    Article  PubMed  Google Scholar 

  • Xu X, Chu AY, Pasha TL, Elder DE, Zhang PJ (2002) Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas. Am J Surg Pathol 26:82–87

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aditya Raghunathan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Raghunathan, A. (2012). Immunohistochemistry in the Differential Diagnosis of Adult and Pediatric Brain Tumors. In: Hayat, M. (eds) Pediatric Cancer, Volume 2. Pediatric Cancer, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2957-5_13

Download citation

Publish with us

Policies and ethics